Glypican-3结构、生物学功能及其肝细胞癌靶向治疗研究进展


江舒雅1 , 陈 春2 , 付 静3,* , 陈啸飞3,4,*
1海军军医大学基础医学院,上海 200433 2上海交通大学附属第九人民医院药剂科,上海 201999 3海军军医 大学附属东方肝胆外科医院,生物信号转导研究中心,上海 200438 4海军军医大学药学院,上海 200433

摘 要:

肝细胞癌(hepatocellular carcinoma, HCC)是最常见的恶性肿瘤之一,但现有治疗方法效果均不甚理想。磷脂酰肌醇蛋白聚糖-3 (glypican-3, GPC3)是肝癌诊断的特异性生物标志物,也是HCC靶向治疗的潜在靶标。近年来,针对GPC3蛋白的靶向治疗包括抗体、抗体-药物偶联物(ADC)、免疫毒素、肿瘤疫苗、靶向肽、嵌合抗原受体、基因治疗等,并且以其为靶点进行了大量药物的研发和细胞治疗研究,其中有一些已经进入了临床试验,如GPC3人源化单克隆抗体GC33、GPC3多肽疫苗、以GPC3为靶点的嵌合抗原受体修饰T细胞(CAR-T)等。可见,基于GPC3的HCC靶向治疗已经成为目前的研究热点。该文将从GPC3的分子结构、生物学功能及靶向GPC3的HCC治疗方法三个方面进行综述,以期为GPC3的功能研究与靶向HCC的

治疗药物和策略研究提供思路。


通讯作者:付 静 , Email:fujing-724@163.com 陈啸飞 , Email:xfchen2010@163.com

Advances in structure, biological functions of glypican-3 and its targeted therapy for hepatocellular carcinoma
JIANG Shu-Ya1 , CHEN Chun2 , FU Jing3,* , CHEN Xiao-Fei3,4,*
1School of Basic Medicine, Naval Medical University, Shanghai 200433, China 2Department of Pharmacy, Shanghai 9th People’s Hospital, Shanghai Jiao Tong University, Shanghai 201999, China 3Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China 4School of Pharmacy, Naval Medical University, Shanghai 200433, China

Abstract:

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, but the effect of existing

treatment methods is not satisfactory.  Phosphatidylinositol proteoglycan-3 (GPC3) is a specific biomarker for the diagnosis and a potential target molecule for targeted therapy of HCC. In recent years, targeted therapy for GPC3 protein, includes antibodies, antibody-drug conjugates (ADC) and immunotoxins, tumor vaccines, targeting peptides, chimeric antigen receptors, gene therapy, etc. And with it as the target, a large number of drugs have been developed, some of which have entered clinical trials, such as GPC3 humanized monoclonal antibody GC33, GPC3 polypeptide vaccine, chimeric antigen receptor modified T cells (CAR-T) targeting GPC3, etc. It can be seen that

GPC3-based targeted therapy for HCC has become a research hotspot at present. In this review, we will summarize the molecular structure and the biological function of GPC3, and the treatment methods of HCC targeting GPC3.


Communication Author:FU Jing , Email:fujing-724@163.com CHEN Xiao-Fei , Email:xfchen2010@163.com

Back to top